Intercure Ltd.
About Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $55.8M
- Gross margin
- 53.9%
- Operating margin
- -1.1%
- Net margin
- -5.2%
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.7B
- Cost of revenue
- $1.2B
- Gross profit
- $1.4B
- Operating expenses
- $1.5B
- Operating income
- -$28.9M
- Income tax
- $26.6M
- Net income
- -$138.5M
- EPS (basic)
- $-1.85
- EPS (diluted)
- $-1.85
Balance sheet
- Total assets
- $7.3B
- Current assets
- $1.4B
- Total liabilities
- $4.3B
- Current liabilities
- $1.2B
- Shareholders’ equity
- $3.0B
Cash flow
- Operating cash flow
- $198.3M
- Investing cash flow
- -$1.7B
- Financing cash flow
- $1.7B
- Net cash flow
- $218.8M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $55.8M
- EPS (diluted)
- $-1.85
- Shares outstanding
- 56.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 1, 2019
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Revenue grew 127% from FY2014 to FY2017.
- Gross margin of 53.9%, net margin -5.2%.
- Trading 43% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Intercure Ltd..
Write a review
News about Intercure Ltd.
News & sentiment via Polygon.io
